mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0008 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.001 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
0.001 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.002 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |